Indolidan

DB19499ExperimentalSmall molecule

Indolidan is a small molecule drug. The usage of the INN stem '-dan' in the name indicates that Indolidan is a cardiac stimulant, pimobendan derivative. Indolidan has a monoisotopic molecular...

Mechanism: Pharmacologically active on Cyclic nucleotide phosphodiesterase and Phosphodiesterase 3
Curator reviewed
Formula / weight: C₁₄H₁₅N₃O₂ · 257.293 g/mol (avg)
Code names: LY-195115

Resolves to

Compound

UNII0751ZOW7ORCAS100643-96-7ChEMBLCHEMBL38224ChEBI748138PubChem5284402

Structure

InChIKeyLZCQFJKUAIWHRW-UHFFFAOYSA-NSMILESCC1(C)C(=O)NC2=CC=C(C=C12)C1=NNC(=O)CC1

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which companies are running trials of Indolidan, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account